无创氧疗策略与急性低氧性呼吸衰竭成人全因死亡率的关联:系统综述与荟萃分析
该网络荟萃分析纳入25项随机临床试验共3804例急性低氧性呼吸衰竭成人患者,比较头盔无创通气、面罩无创通气、高流量鼻氧与标准氧疗。与标准氧疗相比,头盔无创通气(RR 0.40,95%CrI 0.24-0.63)和面罩无创通气(RR 0.83,95%CrI 0.68-0.99)与较低死亡风险相关。
要点
- 头盔无创通气较标准氧疗显著降低死亡风险(RR 0.40,95%CrI 0.24-0.63,低确定性)。
- 面罩无创通气较标准氧疗降低死亡风险(RR 0.83,95%CrI 0.68-0.99,中等确定性)。
- 头盔、面罩无创通气及高流量鼻氧均与较低插管风险相关。
核心结论
- 在急性低氧性呼吸衰竭成人中,与标准氧疗相比,无创氧疗策略与较低死亡风险相关。
- 各无创氧疗策略的相对获益仍需进一步研究阐明。
研究设计与样本
- 系统综述与贝叶斯框架网络荟萃分析,检索MEDLINE、Embase、PubMed、Cochrane Central Register of Controlled Trials、CINAHL、Web of Science和LILACS,自建库至2020年4月。
- 纳入25项随机临床试验,共3804例急性低氧性呼吸衰竭成人患者,比较高流量鼻氧、面罩无创通气、头盔无创通气和标准氧疗。
- 由两名评价者独立提取数据,采用Cochrane偏倚风险工具评估,并使用GRADE方法评级证据确定性。
主要发现
- 与标准氧疗相比,头盔无创通气与较低死亡风险相关(RR 0.40,95%CrI 0.24-0.63;绝对风险差 -0.19,95%CrI -0.37至-0.09;低确定性),基于21项研究3370例患者。
- 与标准氧疗相比,面罩无创通气与较低死亡风险相关(RR 0.83,95%CrI 0.68-0.99;绝对风险差 -0.06,95%CrI -0.15至-0.01;中等确定性),基于21项研究3370例患者。
- 头盔无创通气与较低插管风险相关(RR 0.26,95%CrI 0.14-0.46;绝对风险差 -0.32,95%CrI -0.60至-0.16;低确定性),基于25项研究3804例患者。
- 面罩无创通气与较低插管风险相关(RR 0.76,95%CrI 0.62-0.90;绝对风险差 -0.12,95%CrI -0.25至-0.05;中等确定性),基于25项研究3804例患者。
- 高流量鼻氧与较低插管风险相关(RR 0.76,95%CrI 0.55-0.99;绝对风险差 -0.11,95%CrI -0.27至-0.01;中等确定性),基于25项研究3804例患者。
关键数值与推荐
- 主要结局为90天内全因死亡率;次要结局为30天内气管插管。
- 头盔无创通气降低死亡风险:RR 0.40(95%CrI 0.24-0.63),绝对风险差 -0.19(95%CrI -0.37至-0.09),低确定性。
- 面罩无创通气降低死亡风险:RR 0.83(95%CrI 0.68-0.99),绝对风险差 -0.06(95%CrI -0.15至-0.01),中等确定性。
- 头盔无创通气降低插管风险:RR 0.26(95%CrI 0.14-0.46),绝对风险差 -0.32(95%CrI -0.60至-0.16),低确定性。
- 面罩无创通气与高流量鼻氧降低插管风险:面罩RR 0.76(95%CrI 0.62-0.90)、高流量鼻氧RR 0.76(95%CrI 0.55-0.99),均为中等确定性。
临床怎么用
- 对急性低氧性呼吸衰竭成人,可优先考虑无创氧疗策略而非单纯标准氧疗以降低死亡和插管风险。
- 选择具体策略时需结合患者耐受性、局部条件与证据确定性,头盔无创通气证据确定性较低。
局限性
- 因插管缺乏盲法,插管结局的偏倚风险被评为高。
- 各无创氧疗策略的相对获益尚不明确,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Treatment with noninvasive oxygenation strategies such as noninvasive ventilation and high-flow nasal oxygen may be more effective than standard oxygen therapy alone in patients with acute hypoxemic respiratory failure. OBJECTIVE: To compare the association of noninvasive oxygenation strategies with mortality and endotracheal intubation in adults with acute hypoxemic respiratory failure. DATA SOURCES: The following bibliographic databases were searched from inception until April 2020: MEDLINE, Embase, PubMed, Cochrane Central Register of Controlled Trials, CINAHL, Web of Science, and LILACS. No limits were applied to language, publication year, sex, or race. STUDY SELECTION: Randomized clinical trials enrolling adult participants with acute hypoxemic respiratory failure comparing high-flow nasal oxygen, face mask noninvasive ventilation, helmet noninvasive ventilation, or standard oxygen therapy. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted individual study data and evaluated studies for risk of bias using the Cochrane Risk of Bias tool. Network meta-analyses using a bayesian framework to derive risk ratios (RRs) and risk differences along with 95% credible intervals (CrIs) were conducted. GRADE methodology was used to rate the certainty in findings. MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause mortality up to 90 days. A secondary outcome was endotracheal intubation up to 30 days. RESULTS: Twenty-five randomized clinical trials (3804 participants) were included. Compared with standard oxygen, treatment with helmet noninvasive ventilation (RR, 0.40 [95% CrI, 0.24-0.63]; absolute risk difference, -0.19 [95% CrI, -0.37 to -0.09]; low certainty) and face mask noninvasive ventilation (RR, 0.83 [95% CrI, 0.68-0.99]; absolute risk difference, -0.06 [95% CrI, -0.15 to -0.01]; moderate certainty) were associated with a lower risk of mortality (21 studies [3370 patients]). Helmet noninvasive ventilation (RR, 0.26 [95% CrI, 0.14-0.46]; absolute risk difference, -0.32 [95% CrI, -0.60 to -0.16]; low certainty), face mask noninvasive ventilation (RR, 0.76 [95% CrI, 0.62-0.90]; absolute risk difference, -0.12 [95% CrI, -0.25 to -0.05]; moderate certainty) and high-flow nasal oxygen (RR, 0.76 [95% CrI, 0.55-0.99]; absolute risk difference, -0.11 [95% CrI, -0.27 to -0.01]; moderate certainty) were associated with lower risk of endotracheal intubation (25 studies [3804 patients]). The risk of bias due to lack of blinding for intubation was deemed high. CONCLUSIONS AND RELEVANCE: In this network meta-analysis of trials of adult patients with acute hypoxemic respiratory failure, treatment with noninvasive oxygenation strategies compared with standard oxygen therapy was associated with lower risk of death. Further research is needed to better understand the relative benefits of each strategy.
引用
- Ferreyro BL, Angriman F, Munshi L, et al. Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis. JAMA. 2020. PMID: 32496521. doi:10.1001/jama.2020.9524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。